Discovery and Validation of an Ancillary Genomic Test of Malignancy for Primary Melanocytic Tumors

Ismael A. Vergara; Nigel Maher; Alison J. Potter; Elizabeth C. Paver; Jordan W. Conway; Serigne Lo; Andrew J. Colebatch; Georgina V. Long; James S. Wilmott; Richard A Scolyer

doi:10.1158/1078-0432.ccr-24-1902

Related publications

Article2025

Data from Discovery and Validation of an Ancillary Genomic Test of Malignancy for Primary Melanocytic Tumors

Ismael A. Vergara, Nigel Maher, Alison J. Potter, Elizabeth C. Paver, Jordan W. Conway, Serigne Lo, Andrew J. Colebatch, Georgina V. Long, James S. Wilmott, Richard A Scolyer

Article2025

Figure S2 from Discovery and Validation of an Ancillary Genomic Test of Malignancy for Primary Melanocytic Tumors

Ismael A. Vergara, Nigel Maher, Alison J. Potter, Elizabeth C. Paver, Jordan W. Conway, Serigne Lo, Andrew J. Colebatch, Georgina V. Long, James S. Wilmott, Richard A Scolyer

Article2025

Figure S1 from Discovery and Validation of an Ancillary Genomic Test of Malignancy for Primary Melanocytic Tumors

Ismael A. Vergara, Nigel Maher, Alison J. Potter, Elizabeth C. Paver, Jordan W. Conway, Serigne Lo, Andrew J. Colebatch, Georgina V. Long, James S. Wilmott, Richard A Scolyer

Article2025

Figure S6 from Discovery and Validation of an Ancillary Genomic Test of Malignancy for Primary Melanocytic Tumors

Ismael A. Vergara, Nigel Maher, Alison J. Potter, Elizabeth C. Paver, Jordan W. Conway, Serigne Lo, Andrew J. Colebatch, Georgina V. Long, James S. Wilmott, Richard A Scolyer

Preprint2025

Table S6 from Discovery and Validation of an Ancillary Genomic Test of Malignancy for Primary Melanocytic Tumors

Ismael A. Vergara, Nigel Maher, Alison J. Potter, Elizabeth C. Paver, Jordan W. Conway, Serigne Lo, Andrew J. Colebatch, Georgina V. Long, James S. Wilmott, Richard A Scolyer

Discovery and Validation of an Ancillary Genomic Test of Malignancy for Primary Melanocytic Tumors

Abstract

Discussion(0)

Related publications

Data from Discovery and Validation of an Ancillary Genomic Test of Malignancy for Primary Melanocytic Tumors

Figure S2 from Discovery and Validation of an Ancillary Genomic Test of Malignancy for Primary Melanocytic Tumors

Figure S1 from Discovery and Validation of an Ancillary Genomic Test of Malignancy for Primary Melanocytic Tumors

Figure S6 from Discovery and Validation of an Ancillary Genomic Test of Malignancy for Primary Melanocytic Tumors

Table S6 from Discovery and Validation of an Ancillary Genomic Test of Malignancy for Primary Melanocytic Tumors